-
Kyiv in mourning after 24 killed as Ukraine, Russia swap POWs
-
Beckham becomes first British billionaire sportsman
-
Aussie star, Danish clubbing ode through to Eurovision final
-
German Oscar winner Huller feels war guilt 'every day'
-
Thai lawmakers vote to revive clean air bill
-
Bayern warn that Canada's Davies struggling to be fit for World Cup
-
Long-serving Coleman to end Everton career at end of season
-
Energy-hungry German industries in decline since Ukraine war: data
-
Gordon may have made last Newcastle appearance: Howe
-
Denmark's Queen Margrethe has angioplasty in hospital: palace
-
Civilians caught in war of drones in eastern DR Congo
-
French city reels from teen killing in drug-linked shooting
-
NZ passenger from hantavirus cruise quarantines in Taiwan
-
Sci-fi or battlefield reality? Ukraine's bet on drone swarms
-
Russia, Ukraine swap 205 prisoners of war each
-
Southeast Asia's largest dinosaur identified in Thailand
-
Rapprochement, debates, dissidents: US presidential visits to China
-
Indian magnate Adani agrees multi-million-dollar penalty in US court case
-
Drones to fight school shooters? One US company says yes
-
Mines 'draining Turkey's water sources', environmentalists warn
-
Zimbabwe tobacco hits new highs under smallholder contracts
-
War imperils rare vultures' yearly odyssey to the Balkans
-
Russian border city shrugs off Baltic fears of attack
-
Bitter church row divides Armenia ahead of elections
-
India hikes fuel prices as Middle East war strains supplies
-
Injured Mitoma fails to make Japan's World Cup squad
-
Malaysia PM says not opposed to fugitive financier's bid for pardon
-
Passenger from hantavirus cruise quarantines on remote Pitcairn Island
-
Duplantis kicks off Diamond League season in China
-
Arsenal scent Premier League glory
-
Russia pummels Kyiv, killing at least 24 and denting peace hopes
-
Rare South-North Korea football match sells out in 12 hours
-
Six hantavirus cruise passengers land in Australia
-
Markets wait on Trump-Xi summit, Seoul hits record
-
Solomon Islands elects opposition leader Matthew Wale as PM
-
Football: 2026 World Cup stadium guide
-
Hearts must run Celtic gauntlet to claim historic Scottish title
-
All at stake for Bundesliga relegation battlers on final day
-
Trump traded hundreds of millions in US securities in 2026
-
Can World Cup fuel North America's soccer boom?
-
Bulgaria's pro-Russians seek place after Radev win
-
Canada's Cohere embraces 'low drama' amid AI giant tumult
-
Sci-fi or battlefield reality? Ukraine's bet on swarm drones
-
India seeks trade, energy stability on UAE-Europe tour
-
Five things to look out for in La Liga this weekend
-
Man City battle 'fatigue' ahead of FA Cup final clash with troubled Chelsea
-
Egypt farmers hit by Iran war price surge
-
Harry Styles: from teen heart-throb to music icon
-
CIA director visits Cuba as communist island runs out of oil
-
Seahawks face Patriots in Super Bowl rematch to open NFL season
US regulator approves new generic abortion pill, conservatives outraged
US regulators have approved an additional generic version of the abortion pill mifepristone, a normally routine move that nevertheless angered anti-abortion activists.
A number of conservative figures and anti-abortion groups decried the regulatory step, with the institution Students for Life Action calling it "a stain on the Trump presidency."
The drugmaker Evita said on its website the US Food and Drug Administration had this week approved the company's generic tablet, which is currently approved to end pregnancies up to 70 days of gestation.
The medication is used in the majority of abortions in the United States, and also routinely used for managing early miscarriage.
The FDA originally approved mifepristone in 2000, and another generic already exists.
Approvals of additional generics are typically routine.
But Marjorie Dannenfelser, president of the organization Susan B. Anthony Pro-Life America, called the approval "reckless" and "unconscionable" in a statement Thursday.
Senator Josh Hawley, a Republican from Missouri, said on X he had "lost confidence" in FDA leadership while former vice president Mike Pence posted it was "a complete betrayal of the pro-life movement that elected President Trump."
Pence also called for the dismissal of Robert F. Kennedy Jr, Trump's controversial health chief.
The ruckus comes weeks after Kennedy and FDA Commissioner Marty Makary reportedly delivered a letter to 22 Republican attorneys general saying the FDA was conducting a new review of mifepristone's safety.
Abortion rights organizations have dubbed that a blatant attempt to undermine health care access, and a coalition of attorneys general from more than a dozen Democratic-led states vowed to protect availability of the drug.
The American Medical Association has called the prescription drug "exceedingly safe and effective" and said restricting access to mifepristone would "jeopardize public health."
That take echoes the positions of many leading medical institutions.
Mifepristone, which prevents pregnancy progression, is generally used in combination with misoprostol, which empties the uterus.
O.Karlsson--AMWN